Your browser doesn't support javascript.
loading
SIX4, a potential therapeutic target for estrogen receptor-positive breast cancer patients, is associated with low promoter methylation level.
Wu, Hua-Tao; Wu, Zheng; Hou, Yan-Yu; Fang, Ze-Xuan; Wu, Bing-Xuan; Deng, Yu; Cui, Yu-Kun; Liu, Jing.
Afiliação
  • Wu HT; Department of General Surgery, First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Wu Z; Laboratory for Diagnosis & Treatment of Breast Cancer, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Hou YY; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Fang ZX; Department of Physiology/Changjiang Scholar's Laboratory, Shantou University Medical College, Shantou, 515041, China.
  • Wu BX; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Deng Y; Department of Physiology/Changjiang Scholar's Laboratory, Shantou University Medical College, Shantou, 515041, China.
  • Cui YK; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Liu J; Department of Physiology/Changjiang Scholar's Laboratory, Shantou University Medical College, Shantou, 515041, China.
Epigenomics ; 15(18): 911-925, 2023 09.
Article em En | MEDLINE | ID: mdl-37905439
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Epigenomics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Epigenomics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido